CMMS-GCL: cross-modality metabolic stability prediction with graph contrastive learning

被引:1
作者
Du, Bing-Xue [1 ,2 ]
Long, Yahui [3 ]
Li, Xiaoli [2 ]
Wu, Min [2 ]
Shi, Jian-Yu [1 ]
机构
[1] Northwestern Polytech Univ, Sch Life Sci, Xian 710072, Peoples R China
[2] ASTAR, Inst Infocomm Res I2R, Singapore 138632, Singapore
[3] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore
关键词
DRUG-METABOLISM; DISCOVERY;
D O I
10.1093/bioinformatics/btad503
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Motivation: Metabolic stability plays a crucial role in the early stages of drug discovery and development. Accurately modeling and predicting molecular metabolic stability has great potential for the efficient screening of drug candidates as well as the optimization of lead compounds. Considering wet-lab experiment is time-consuming, laborious, and expensive, in silico prediction of metabolic stability is an alternative choice. However, few computational methods have been developed to address this task. In addition, it remains a significant challenge to explain key functional groups determining metabolic stability. Results: To address these issues, we develop a novel cross-modality graph contrastive learning model named CMMS-GCL for predicting themetabolic stability of drug candidates. In our framework, we design deep learning methods to extract features for molecules from two modality data, i.e. SMILES sequence and molecule graph. In particular, for the sequence data, we design a multihead attention BiGRU-based encoder to preserve the context of symbols to learn sequence representations of molecules. For the graph data, we propose a graph contrastive learning-based encoder to learn structure representations by effectively capturing the consistencies between local and global structures. We further exploit fully connected neural networks to combine the sequence and structure representations for model training. Extensive experimental results on two datasets demonstrate that our CMMS-GCL consistently outperforms seven state-of-the-art methods. Furthermore, a collection of case studies on sequence data and statistical analyses of the graph structure module strengthens the validation of the interpretability of crucial functional groups recognized by CMMS-GCL. Overall, CMMS-GCL can serve as an effective and interpretable tool for predicting metabolic stability, identifying critical functional groups, and thus facilitating the drug discovery process and lead compound optimization. Availability and implementation: The code and data underlying this article are freely available at https://github.com/dubingxue/CMMS-GCL.
引用
收藏
页数:11
相关论文
empty
未找到相关数据